Hormones have to be transported from their sites of synthesis to their target organs. For lipophilic hormones, such as steroids and thyroid hormones, transport is accomplished by binding to specific serum proteins, in the case of thyroxine (T4) and tri-iodothyronine (T3) to thyroxine-binding globulin (TBG) and prealbumin (PA). Normally about 70% of circulating T4 and 7 5 4 0 % of T3 is bound to TBG, about 20% of T4 and 10% of T3 to PA and 10-15% of each to albumin, which has a low affiity but high capacity for both hormones [l, 21. Apart from facilitating transport, binding to serum protein prevents excessive loss of hormone into the urine by glomerular filtration or flooding into cells, and may provide a readily available reservo@ in times of need. The union between binding proteins and their ligands is reversible, so that a small proportion of hormone is non-proteinbound or 'free', in equilibrium with that which is protein-bound. For T4 this free fraction is normally 0.02-0.04% of the total serum T4 concentration, for T3 about 0.3% [3,4].
70% of circulating T4 and 7 5 4 0 % of T3 is bound to TBG, about 20% of T4 and 10% of T3 to PA and 10-15% of each to albumin, which has a low affiity but high capacity for both hormones [l, 21. Apart from facilitating transport, binding to serum protein prevents excessive loss of hormone into the urine by glomerular filtration or flooding into cells, and may provide a readily available reservo@ in times of need. The union between binding proteins and their ligands is reversible, so that a small proportion of hormone is non-proteinbound or 'free', in equilibrium with that which is protein-bound. For T4 this free fraction is normally 0.02-0.04% of the total serum T4 concentration, for T3 about 0.3% [3, 4] .
The major binding proteins of T4 and T3 will briefly be described and the nature of free T4 and T3 considered.
Thyroxine-binding globulin
TBG is an a-globulin that migrates electrophoretically between al-and a2-globulin. Its purification to near-homogeneity has been reported by several groups and its molecular weight is generally estimated to lie between 54 000 and 65 000 [5-71.
TBG possesses a single polypeptide chain but Abbreviations: PA, prealbumin; RBP, retinolbinding protein; T3, tri-iodothyronine; T4, thyroxine; TBG, thyroxine-binding globulin.
Correspondence PA is also synthesized in the liver and may be regarded as an acute phase reactant, its serum concentration falling rapidly in acute illness or stress. This has been shown to result primarily from reduced hepatic synthesis, not increased degradation or loss [26, 27] .
No hereditary absence of PA has been reported, although hyperthyroxinaemia due to abnormally increased binding to PA has been described. This is thought to be due to a structural alteration in the protein, giving rise to increased affinity. The mode of inheritance of this trait has not been fully elucidated, but it is known not to be X-linked because male-to-male transmission has been observed [28] .
Albumin
Albumin normally acts as a nonspecific 'sponge', mopping up a small proportion of T4 and T3. It has a very large capacity for both hormones with a low binding affinity. Each molecule of albumin is thought to possess one relatively high affinity binding site for T4, and a number of secondary binding sites of lower affinity, perhaps as many as six [29] .
Recently, some euthyroid subjects have been shown to possess an abnormal form of albumin with a high affinity for T4, of the order of that of TBG. This causes a high circulating total T4 concentration as would be found with high TBG; the free T4 concentration is normal and the patients are euthyroid. The disorder is inherited as a dominant trait and is of no clinical significance once it has been recognized as the explanation of an inordinately high serum T4 concentration [30] .
Free T4 and T3
Because the processes of binding of T4 and T3 to and their release from serum proteins are considerably faster than their metabolism within cells, the concentration of free T4 and T3 as measured in vitro is thought to represent the rate of unidirectional transfer [31] of hormone from plasma t o tissue. The mode of entry into cells is usually assumed to be by passive diffusion since both thyroid hormones and cell membranes are lipophilic in nature (lipid mediation) [32] . This concept confers great biological significance on the concentration of free T4 and T3 in the circulation, and many systems in vitro have been established to facilitate their measurement either directly or indirectly (see below). Although such measurements have proved most valuable in clinical practice, there are serious reservations about the scientific validity of equating determinations of free hormone concentration in vitro with conditions that might obtain in vivo. Ekins, for instance, has argued that free hormone as measured by conventional techniques represents the equilibrium concentration within the bulk of a fluid. If an inert semipermeable membrane exists between two fluid bulks and hormones migrate across it, the hormone concentration of free hormone in fluid close to the membrane decreases relative to that in the main fluid bulk. In biological terms this might mean that available hormone in blood plasma at the cell surface (a semipermeable membrane) would be less than appeared from any measurement by free hormone assays, although they might bear a proportional relationship to it [33] . In a development of this argument Ekins et al. have suggested that in tissues with high rates of uptake, total hormone concentration as well as free may be an important factor modulating uptake [34] . Further, they suggest that the relative proportions of individual transport proteins may affect the ratio of T3 to T4 taken up. It should be pointed out, however, that whilst the mathematical development of this proposition appears sound there is no biochemical evidence that rates of delivery of hormone are so modulated. A further reservation exists about the inert role of cell membranes, as stereospecific receptors for thyroid hormones have been demonstrated in some cells, e.g. on rat liver cell membranes. Translocation of thyroid hormones into the liver, and possibly other tissues, might thus be via energy-dependent and specific processes [35, 36] . Another factor to be considered is the possibility of endocytosis of protein-bound ligands into the cell without prior dissociation; this has clearly been demonstrated for vitamin A and retinol-binding protein, the transcobalamins and vitamin B12, low-density lipoprotein and cholesterol and transferrin-iron complexes, but there is little evidence that thyroid hormones enter cells by the same mechanism to any significant extent. If this were to occur, free hormone determination would not necessarily bear a relationship to cellular uptake. Finally, the amount of hormone within a cell must obviously affect the cell's ability to facilitate entry, and this depends on intracellular binding capacity for the hormone, its metabolism within and egress from the cell. In thyroid hormone-responsive cells such as liver and kidney, high-affinity limited-capacity binding sites for T3 have been identified in nuclei and on the inner mitochondria1 membrane [37-391. T3 bound to these sites probably accounts for no more than 10% of intracellular hormone under normal euthyroid conditions. Further binding sites for T3 are found in the cytosol; these are of lower affinity but much higher capacity [40] . The nuclear binding sites are probably true receptors for T3, in that binding of the hormone is a necessary prelude to initiation of its action on nuclear protein kinases; they may not be the only T3 receptors present in the cell capable of mediating activity. The cytosolic binding proteins appear to function as intracellular transport proteins, facilitating passage of T3 from the cell membrane and mitochondrion to the nucleus. The function of mitochondrion-bound T3 is uncertain.
Despite these reservations about the concept and role of free T4 and T3, clinicians rely heavily on techniques that measure or reflect free T4 (and to a lesser extent free T3) and an excellent correlation exists between such measurements and clinical thyroid status. In practice, the most commonly used method for determining free T4 makes use of a calculated free T4 index [41, 42] . This is based on a relationship between the concentrations of total and free T4 and their major binding protein, TBG, as defined by the Law of Mass Action:
[ This formulation is clearly an' oversimplification as it fails to take into account the role of other binding proteins for T4 (prealbumin and albumin), which assume greater significance when serum TBG concentration is below about 5 mg/l, as may be found in genetic disorders. It is possible to make allowance for the relative influence of each protein on free hormone concentration and more complex formulae have been proposed for determination of free T4 [44, 45] . Other indirect methods of measuring free T4 are based on the ratio of T4/TBG concentrations [ 171 or the use of equilibrium dialysis [3] to establish the fraction of hormone that is non-protein bound; the free hormone concentration can then be calculated from the total hormone concentration.
Several direct methods have been described in which preliminary separation of free T4 from that bound to proteins is achieved by use of equilibrium dialysis; direct radioimmunoassay can then be carried out on the separated hormone [4] . The uncertainty of many of these techniques is illustrated by the wide range of values reported for the concentration of free T4 (20 to almost 500 pmol/l) by different groups. The best methods of calculating free T4 and free T3 and the currently accepted best methods of direct or indirect assay give values of about 830pmol/l for T4 and 3-8pmol/l for T3 [33] .
Methods of measuring free hormone based on equilibrium dialysis are generally unsuitable for use in the routine iaboratory handling hundreds of samples per week. This has prompted the introduction by commercial companies of methods designed to measure free hormone by techniques less demanding of time and labour. These tend not to have been viewed with universal admiration [46- 491. Nevertheless, two, Corning's Immunophase and Amersham International's Amerlex Free T4 assays, have come into widespread use, if not uncritical acceptance in the U.K. Therefore the basic principles underlying these assays will be described briefly. The Corning Immunophase assay is based on the rate of uptake of hormone by an exogenous binding agent to which the serum is exposed. In practice, because the concentration of binding agent is fixed and rate of uptake is assumed to be solely proportional to free hormone concentration, the rate is determined by the amount of uptake at a single time point. This in turn is assessed by uptake of added radioactive T4, where radioactivity attached to the exogenous binder is inversely proportional to free hormone concentration. Allowance, however, has to be made for diminution of the specific radioactivity of the radioactive label by serum total T4, otherwise sera with identical actual free hormone concentrations but different total T4 concentrations due to differences in TBG would have different measured free hormone concentrations.
In contrast to the above, the Amerlex assay is carried out at equilibrium. A binding agent directed against a T4 analogue together with the radioactive analogue are introduced into the sample. Endogenous T4 is also capable of interacting with the binder; thus competitive displacement of radioactive analogue occurs. The analogue is said to have little if any binding to serum protein. Therefore the concentrations of analogue and binder can be so adjusted that only a fraction of free T4 is sampled in the competitive displacement. Free hormone concentration is inversely proportional to the amount of analogue attached to the binder at equilibrium. When introduced for general use, both assays come under critical review for various technical reasons. Nevertheless, when their use is confined to the purpose for which they were intended, the diagnosis of uncomplicated thyroid dysfunction, the results are not worse than those obtained by conventional free T4 indices. On the borderline between euthyroidism and hyperthyroidism free T4 and more particularly free T3 should in theory be more sensitive parameters than their respective total hormone concentrations.
The speed, simplicity and ruggedness of the tests may also allow saving in money and time in comparison with conventional tests. However, quantitative results obtained in circumstances outside the above restriction should be viewed with caution. This applies to all free T4 and T3 assays, including equilibrium dialysis, since the factors which may modulate observed values have not been fully elucidated, as evidenced by the curious results in certain non-thyroidal illness [50, 51] .
The importance of the above considerations lies in the acceptance of the biological significance of free T4 concentration and the relationship with its binding proteins. If the concentrations of TBG and PA were fixed and invariable, total T4 and T3 concentrations would for the most part reflect the activity of the thyroid gland. But the concentrations of both TBG and PA vary greatly in response to acute and chronic influences, so there is a need to correct for the effect of variations in binding protein concentration on the concentration of these hormones.
Recent studies of late pregnancy have provided unexpected results. High circulating oestrogen concentrations cause a marked increase in plasma TBG with a consequent rise in total T4. Free T4 concentrations, however, have been reported as low [52-541, whether measured by direct assay, inferred from T4/TBG ratios or calculated from the formula of Prince & Ramsden [44] . It has been suggested that the reduction of free T4 concentration in late pregnancy is 'physiological' but in view of the above caveat a full explanation is still awaited.
From the practical point of view, most of the techniques available for measuring or deriving a free hormone concentration, whether 'in house' or commercial kits, provide a reasonable guide to the thyroid status of a patient. It is only in subjects with very high TBG concentrations (late pregnancy, hereditary) or very low (hereditary) that difficulties arise and more refined techniques may be required. The emphasis in development must lie in the direction of reducing the cost of thyroid function tests rather than improving their diagnostic performance. Only then would it bejustified to introduce routine screening tests for thyroid disease, which its prevalence in the community might warrant. 
